Status:
COMPLETED
The Safety and toleRability of UltraviSt in Patients Undergoing Cardiac CaTheterization (TRUST)
Lead Sponsor:
Bayer
Conditions:
Angiocardiography
Eligibility:
All Genders
Brief Summary
This study is to collect the information of Ultravist® in the patients indicated for the coronary angiography or PCI, like rate of ADR in patients, the dose for different indications, image quality to...
Eligibility Criteria
Inclusion
- Female and male patients who receive Ultravist® for coronary angiography or PCI can be included in the study
Exclusion
- Patients who are or are suspected in pregnancy or nursery
- Patients with the contraindications for Ultravist
- Patients with the contraindications for cardiac catheterization
Key Trial Info
Start Date :
August 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
17513 Patients enrolled
Trial Details
Trial ID
NCT01206257
Start Date
August 1 2010
End Date
September 1 2011
Last Update
June 11 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, China